US4309430A
(en)
|
1980-06-27 |
1982-01-05 |
Merck & Co., Inc. |
Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same
|
JPS62270623A
(ja)
|
1985-12-07 |
1987-11-25 |
Daicel Chem Ind Ltd |
ビス(4−アミノフエニル)ピラジンおよびその製法、ならびにポリイミドおよびその製法
|
JPS63208520A
(ja)
|
1987-02-26 |
1988-08-30 |
Terumo Corp |
ピラジン誘導体を含有する血小板凝集抑制剤
|
US5329012A
(en)
|
1987-10-29 |
1994-07-12 |
The Research Foundation Of State University Of New York |
Bis(acyloxmethyl)imidazole compounds
|
JPH0272370A
(ja)
|
1988-09-07 |
1990-03-12 |
Konica Corp |
電子写真感光体
|
JPH0272372A
(ja)
|
1988-09-07 |
1990-03-12 |
Konica Corp |
電子写真感光体
|
JPH0374370A
(ja)
|
1989-08-16 |
1991-03-28 |
Terumo Corp |
ピラジン誘導体およびこれを含有する血小板凝集抑制剤または抗炎症剤
|
JP2597917B2
(ja)
|
1990-04-26 |
1997-04-09 |
富士写真フイルム株式会社 |
新規な色素形成カプラー及びそれを用いたハロゲン化銀カラー写真感光材料
|
US5572248A
(en)
|
1994-09-19 |
1996-11-05 |
Teleport Corporation |
Teleconferencing method and system for providing face-to-face, non-animated teleconference environment
|
EP0914318A1
(en)
|
1996-05-11 |
1999-05-12 |
Kings College London |
Pyrazines
|
JP4026876B2
(ja)
|
1996-09-05 |
2007-12-26 |
日本食品化工株式会社 |
発光性シクロデキストリン誘導体及びその製造方法
|
JP2002241379A
(ja)
|
1997-03-21 |
2002-08-28 |
Dainippon Pharmaceut Co Ltd |
3−オキサジアゾリルキノキサリン誘導体
|
AU2790999A
(en)
|
1998-03-03 |
1999-09-20 |
Merck & Co., Inc. |
Fused piperidine substituted arylsulfonamides as beta3-agonists
|
DE19826671A1
(de)
|
1998-06-16 |
1999-12-23 |
Hoechst Schering Agrevo Gmbh |
1,3-Oxazolin- und 1,3-Thiazolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
|
TW548275B
(en)
|
1998-07-16 |
2003-08-21 |
Shionogi & Co |
A pyrimidine derivative having antiturnor activity
|
US7023913B1
(en)
|
2000-06-14 |
2006-04-04 |
Monroe David A |
Digital security multimedia sensor
|
DK1150999T3
(da)
*
|
1999-02-05 |
2006-10-30 |
Debiopharm Sa |
Cyclosporinderivater og fremgangsmåde til fremstilling deraf
|
US6738073B2
(en)
|
1999-05-12 |
2004-05-18 |
Imove, Inc. |
Camera system with both a wide angle view and a high resolution view
|
EP1377554A1
(en)
|
1999-06-16 |
2004-01-07 |
University Of Iowa Research Foundation |
Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
|
US7015954B1
(en)
|
1999-08-09 |
2006-03-21 |
Fuji Xerox Co., Ltd. |
Automatic video system using multiple cameras
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
AU782858B2
(en)
|
1999-12-17 |
2005-09-01 |
Novartis Vaccines And Diagnostics, Inc. |
Pyrazine based inhibitors of glycogen synthase kinase 3
|
US6849660B1
(en)
|
2000-08-01 |
2005-02-01 |
Isis Pharmaceuticals, Inc. |
Antimicrobial biaryl compounds
|
JP2002072370A
(ja)
|
2000-08-29 |
2002-03-12 |
Fuji Photo Optical Co Ltd |
ペーパーマガジン及び写真焼付装置
|
JP2002072372A
(ja)
|
2000-09-04 |
2002-03-12 |
Fuji Photo Film Co Ltd |
画像形成用シート体の切断装置
|
US6829391B2
(en)
|
2000-09-08 |
2004-12-07 |
Siemens Corporate Research, Inc. |
Adaptive resolution system and method for providing efficient low bit rate transmission of image data for distributed applications
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
US8085293B2
(en)
|
2001-03-14 |
2011-12-27 |
Koninklijke Philips Electronics N.V. |
Self adjusting stereo camera system
|
US6759657B2
(en)
|
2001-03-27 |
2004-07-06 |
Kabushiki Kaisha Toshiba |
Infrared sensor
|
WO2002080899A1
(fr)
*
|
2001-03-30 |
2002-10-17 |
Eisai Co., Ltd. |
Agent de traitement de maladie digestive
|
US6469002B1
(en)
*
|
2001-04-19 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
DE60229059D1
(de)
|
2001-05-08 |
2008-11-06 |
Univ Yale |
Proteomimetische verbindungen und verfahren
|
SE0102438D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
SE0102439D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
JP2003074370A
(ja)
|
2001-09-05 |
2003-03-12 |
Suzuki Motor Corp |
エンジンのベルト保護装置
|
USRE40794E1
(en)
*
|
2001-09-26 |
2009-06-23 |
Merck & Co., Inc. |
Crystalline forms of carbapenem antibiotics and methods of preparation
|
GB0124939D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
US6992087B2
(en)
|
2001-11-21 |
2006-01-31 |
Pfizer Inc |
Substituted aryl 1,4-pyrazine derivatives
|
AU2002343557A1
(en)
|
2001-11-21 |
2003-06-10 |
Pharmacia And Upjohn Company |
Substituted aryl 1,4-pyrazine derivatives
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
EP2322521B1
(en)
|
2002-02-06 |
2013-09-04 |
Vertex Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of GSK-3
|
BR0307575A
(pt)
|
2002-03-13 |
2004-12-21 |
Janssen Pharmaceutica Nv |
Derivados de sulfonila como inibidores de histona desacetilase
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
TWI319387B
(en)
|
2002-04-05 |
2010-01-11 |
Astrazeneca Ab |
Benzamide derivatives
|
US7043079B2
(en)
|
2002-04-25 |
2006-05-09 |
Microsoft Corporation |
“Don't care” pixel interpolation
|
GB0209715D0
(en)
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
CA2484209C
(en)
|
2002-05-03 |
2013-06-11 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
US7704995B2
(en)
|
2002-05-03 |
2010-04-27 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
KR20050004214A
(ko)
|
2002-05-31 |
2005-01-12 |
에자이 가부시키가이샤 |
피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물
|
AU2003249369A1
(en)
|
2002-06-21 |
2004-01-06 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
WO2004000820A2
(en)
|
2002-06-21 |
2003-12-31 |
Cellular Genomics, Inc. |
Certain aromatic monocycles as kinase modulators
|
WO2004033431A2
(en)
|
2002-10-04 |
2004-04-22 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
US20040075741A1
(en)
|
2002-10-17 |
2004-04-22 |
Berkey Thomas F. |
Multiple camera image multiplexer
|
US7385626B2
(en)
|
2002-10-21 |
2008-06-10 |
Sarnoff Corporation |
Method and system for performing surveillance
|
US20040100560A1
(en)
|
2002-11-22 |
2004-05-27 |
Stavely Donald J. |
Tracking digital zoom in a digital video camera
|
SE0203754D0
(sv)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
SE0203752D0
(sv)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
OA13151A
(en)
|
2003-02-26 |
2006-12-13 |
Sugen Inc |
Aminoheteroaryl compounds as protein kinase inhibitors.
|
US7684624B2
(en)
|
2003-03-03 |
2010-03-23 |
Smart Technologies Ulc |
System and method for capturing images of a target area on which information is recorded
|
ES2308151T3
(es)
|
2003-03-11 |
2008-12-01 |
Pfizer Products Inc. |
Compuestos de pirazina como inhibidores del factor de crecimiento transformante (tgf).
|
EP1606266A4
(en)
|
2003-03-21 |
2008-06-25 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
AU2004224392A1
(en)
|
2003-03-24 |
2004-10-07 |
Merck & Co., Inc. |
Biaryl substituted 6-membered heterocyles as sodium channel blockers
|
GB2400101A
(en)
|
2003-03-28 |
2004-10-06 |
Biofocus Discovery Ltd |
Compounds capable of binding to the active site of protein kinases
|
GB2400514B
(en)
|
2003-04-11 |
2006-07-26 |
Hewlett Packard Development Co |
Image capture method
|
CA2524867A1
(en)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
WO2004103991A1
(fr)
|
2003-05-20 |
2004-12-02 |
'chemical Diversity Research Institute', Ltd. |
Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique
|
US20050123902A1
(en)
*
|
2003-05-21 |
2005-06-09 |
President And Fellows Of Harvard College |
Human papillomavirus inhibitors
|
PE20050206A1
(es)
|
2003-05-26 |
2005-03-26 |
Schering Ag |
Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
|
US7986339B2
(en)
|
2003-06-12 |
2011-07-26 |
Redflex Traffic Systems Pty Ltd |
Automated traffic violation monitoring and reporting system with combined video and still-image data
|
JP2005020227A
(ja)
|
2003-06-25 |
2005-01-20 |
Pfu Ltd |
画像圧縮装置
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
WO2005034952A2
(en)
|
2003-10-07 |
2005-04-21 |
The Feinstein Institute For Medical Research |
Isoxazole and isothiazole compounds useful in the treatment of inflammation
|
US20050116968A1
(en)
|
2003-12-02 |
2005-06-02 |
John Barrus |
Multi-capability display
|
US20080194574A1
(en)
|
2003-12-16 |
2008-08-14 |
Axxima Pharmaceuticals Ag |
Pyrazine Derivatives As Effective Compounds Against Infectious Diseases
|
CA2555402A1
(en)
|
2004-02-12 |
2005-09-01 |
Celine Bonnefous |
Bipyridyl amides as modulators of metabotropic glutamate receptor-5
|
US20050276765A1
(en)
|
2004-06-10 |
2005-12-15 |
Paul Nghiem |
Preventing skin damage
|
US20080153869A1
(en)
|
2004-06-14 |
2008-06-26 |
Bressi Jerome C |
Kinase Inhibitors
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
US7452993B2
(en)
|
2004-07-27 |
2008-11-18 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
JP2008510792A
(ja)
|
2004-08-26 |
2008-04-10 |
ファイザー・インク |
タンパク質チロシンキナーゼ阻害剤としてのアミノヘテロアリール化合物
|
WO2006021884A2
(en)
|
2004-08-26 |
2006-03-02 |
Pfizer Inc. |
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
|
US7730406B2
(en)
|
2004-10-20 |
2010-06-01 |
Hewlett-Packard Development Company, L.P. |
Image processing system and method
|
JP5008569B2
(ja)
|
2004-10-22 |
2012-08-22 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
C−fmsキナーゼのインヒビターとしての芳香族アミド
|
WO2006053342A2
(en)
|
2004-11-12 |
2006-05-18 |
Osi Pharmaceuticals, Inc. |
Integrin antagonists useful as anticancer agents
|
EP1814882A1
(en)
|
2004-11-22 |
2007-08-08 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
JP4810669B2
(ja)
|
2004-11-25 |
2011-11-09 |
コニカミノルタホールディングス株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
GB0428235D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Novel compounds
|
JP2008525453A
(ja)
|
2004-12-27 |
2008-07-17 |
アルコン,インコーポレイティド |
緑内障と、rhoキナーゼを媒介とした他の疾患および症状を治療するためのアミノピラジン・アナログ
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
CA2598456A1
(en)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Heterocyclic substituted piperazines with cxcr3 antagonist activity
|
WO2006114180A1
(de)
|
2005-04-25 |
2006-11-02 |
Merck Patent Gmbh |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
WO2006124874A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Inhibitors of b-raf kinase
|
CA2610884A1
(en)
|
2005-06-09 |
2006-12-21 |
Merck & Co., Inc. |
Inhibitors of checkpoint kinases
|
MX2008001538A
(es)
|
2005-08-02 |
2008-04-04 |
Lexicon Pharmaceuticals Inc |
Aril piridinas y metodos para su uso.
|
WO2007015632A1
(en)
|
2005-08-04 |
2007-02-08 |
Cgk Co., Ltd. |
Atm and atr inhibitor
|
US7394926B2
(en)
|
2005-09-30 |
2008-07-01 |
Mitutoyo Corporation |
Magnified machine vision user interface
|
US7806604B2
(en)
|
2005-10-20 |
2010-10-05 |
Honeywell International Inc. |
Face detection and tracking in a wide field of view
|
AR056786A1
(es)
|
2005-11-10 |
2007-10-24 |
Smithkline Beecham Corp |
Compuesto de 1h- imidazo ( 4,5-c) piridin-2-ilo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion, su uso para preparar unmedicamento, uso de una combinacion que omprende al compuesto y al menos un agente antineoplasico para preparar un medicamento y dicha com
|
CA2630460C
(en)
|
2005-12-01 |
2013-01-08 |
F. Hoffmann-La Roche Ag |
Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
|
EP1970377A4
(en)
|
2005-12-09 |
2013-02-27 |
Meiji Seika Kaisha |
LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THIS AS AN ACTIVE SUBSTANCE
|
JP2009519937A
(ja)
*
|
2005-12-14 |
2009-05-21 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
無脊椎有害生物防除用イソオキサゾリン
|
CA2629342A1
(en)
|
2005-12-22 |
2007-07-05 |
Alcon Research, Ltd. |
(indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
ITMI20060311A1
(it)
|
2006-02-21 |
2007-08-22 |
Btsr Int Spa |
Dispositivo perfezionato di alimentazione di filo o filatio ad una macchina tessile e metodo per attuare tale alimentazione
|
GB0603684D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
TW200800203A
(en)
|
2006-03-08 |
2008-01-01 |
Astrazeneca Ab |
New use
|
DE602007004092D1
(de)
|
2006-03-22 |
2010-02-11 |
Vertex Pharma |
C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen
|
US7574131B2
(en)
|
2006-03-29 |
2009-08-11 |
Sunvision Scientific Inc. |
Object detection system and method
|
MX2008012658A
(es)
|
2006-03-31 |
2008-12-16 |
Schering Corp |
Inhibidores de cinasa.
|
US7629346B2
(en)
|
2006-06-19 |
2009-12-08 |
Hoffmann-La Roche Inc. |
Pyrazinecarboxamide derivatives as CB1 antagonists
|
CN101472912A
(zh)
|
2006-06-22 |
2009-07-01 |
比奥维特罗姆上市公司 |
作为mnk激酶抑制剂的吡啶和吡嗪衍生物
|
JP2009541323A
(ja)
|
2006-06-22 |
2009-11-26 |
マリンクロット インコーポレイテッド |
拡張された共役を有するピラジン誘導体およびその使用
|
EP1900727A1
(en)
|
2006-08-30 |
2008-03-19 |
Cellzome Ag |
Aminopyridine derivatives as kinase inhibitors
|
WO2008037477A1
(en)
|
2006-09-29 |
2008-04-03 |
Novartis Ag |
Pyrazolopyrimidines as p13k lipid kinase inhibitors
|
GB0619342D0
(en)
|
2006-09-30 |
2006-11-08 |
Vernalis R&D Ltd |
New chemical compounds
|
CA2664119A1
(en)
|
2006-10-04 |
2008-04-10 |
F. Hoffmann-La Roche Ag |
3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
|
EP2078016B1
(en)
|
2006-10-19 |
2012-02-01 |
Signal Pharmaceuticals LLC |
Heteroaryl compounds, compositions thereof, and methods of treatment therewith
|
WO2008060907A2
(en)
|
2006-11-10 |
2008-05-22 |
Bristol-Myers Squibb Company |
Pyrrolo-pyridine kinase inhibitors
|
US20080132698A1
(en)
|
2006-11-30 |
2008-06-05 |
University Of Ottawa |
Use of N-oxide compounds in coupling reactions
|
UY30796A1
(es)
|
2006-12-15 |
2008-07-31 |
Bayer Schering Pharma Ag |
3-h-pirazolopiridinas y sales de éstas, composiciones farmacéuticas que las comprenden, métodos para prepararlas, y sus usos
|
WO2008079291A2
(en)
|
2006-12-20 |
2008-07-03 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
PE20081581A1
(es)
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
GB0625659D0
(en)
|
2006-12-21 |
2007-01-31 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
US8314087B2
(en)
|
2007-02-16 |
2012-11-20 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and methods of use
|
CA2679659C
(en)
|
2007-03-01 |
2016-01-19 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
WO2008122375A2
(en)
*
|
2007-04-10 |
2008-10-16 |
Bayer Cropscience Ag |
Insecticidal aryl isoxazoline derivatives
|
JP2008260691A
(ja)
*
|
2007-04-10 |
2008-10-30 |
Bayer Cropscience Ag |
殺虫性アリールイソオキサゾリン誘導体
|
PE20090288A1
(es)
|
2007-05-10 |
2009-04-03 |
Smithkline Beecham Corp |
Derivados de quinoxalina como inhibidores de la pi3 quinasa
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
UY31137A1
(es)
|
2007-06-14 |
2009-01-05 |
Smithkline Beecham Corp |
Derivados de quinazolina como inhibidores de la pi3 quinasa
|
EP2012409A2
(en)
|
2007-06-19 |
2009-01-07 |
Hitachi, Ltd. |
Rotating electrical machine
|
JP2009027904A
(ja)
|
2007-06-19 |
2009-02-05 |
Hitachi Ltd |
回転電機
|
JPWO2008156174A1
(ja)
|
2007-06-21 |
2010-08-26 |
大正製薬株式会社 |
ピラジンアミド化合物
|
MX2009013990A
(es)
|
2007-06-26 |
2010-03-30 |
Lexicon Pharmaceuticals Inc |
Metodos para tratar enfermedades y trastornos mediados por serotonina.
|
CN101808518A
(zh)
|
2007-06-27 |
2010-08-18 |
默沙东公司 |
作为组蛋白脱乙酰酶抑制剂的吡啶基和嘧啶基衍生物
|
GB0713259D0
(en)
|
2007-07-09 |
2007-08-15 |
Astrazeneca Ab |
Pyrazine derivatives 954
|
AR067585A1
(es)
|
2007-07-19 |
2009-10-14 |
Schering Corp |
Compuestos heterociclicos de amidas como inhibidores de la proteincinasa
|
WO2009012482A2
(en)
|
2007-07-19 |
2009-01-22 |
H.Lundbeck A/S |
5-membered heterocyclic amides and related compounds
|
KR20100038119A
(ko)
|
2007-08-01 |
2010-04-12 |
화이자 인코포레이티드 |
피라졸 화합물 및 raf 억제제로서 이의 용도
|
WO2009024825A1
(en)
|
2007-08-21 |
2009-02-26 |
Astrazeneca Ab |
2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors
|
WO2009037247A1
(en)
|
2007-09-17 |
2009-03-26 |
Neurosearch A/S |
Pyrazine derivatives and their use as potassium channel modulators
|
JP2011500778A
(ja)
|
2007-10-25 |
2011-01-06 |
アストラゼネカ・アクチエボラーグ |
ピリジン及びピラジン誘導体−083
|
EP2265270A1
(en)
|
2008-02-04 |
2010-12-29 |
OSI Pharmaceuticals, Inc. |
2-aminopyridine kinase inhibitors
|
CA2716223A1
(en)
|
2008-02-25 |
2009-09-03 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine kinase inhibitors
|
WO2009106444A1
(en)
|
2008-02-25 |
2009-09-03 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine kinase inhibitors
|
PT2250172E
(pt)
|
2008-02-25 |
2011-11-30 |
Hoffmann La Roche |
Inibidores de pirrolpirazina-cinase
|
DK2247592T3
(da)
|
2008-02-25 |
2011-09-26 |
Hoffmann La Roche |
Pyrrolopyrazinkinaseinhibitors
|
TW200940537A
(en)
|
2008-02-26 |
2009-10-01 |
Astrazeneca Ab |
Heterocyclic urea derivatives and methods of use thereof
|
JP2011513332A
(ja)
|
2008-02-29 |
2011-04-28 |
アレイ バイオファーマ、インコーポレイテッド |
癌の治療のためのraf阻害剤としてのn−(6−アミノピリジン−3−イル)−3−(スルホンアミド)ベンズアミド誘導体
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
US8110576B2
(en)
|
2008-06-10 |
2012-02-07 |
Plexxikon Inc. |
Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
|
GB0814364D0
(en)
|
2008-08-05 |
2008-09-10 |
Eisai London Res Lab Ltd |
Diazaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase
|
ES2378513T3
(es)
|
2008-08-06 |
2012-04-13 |
Pfizer Inc. |
Compuestos 2-heterociclilamino piracinas sustituidas en posición 6 como inhibidores de CHK-1
|
KR101846029B1
(ko)
*
|
2008-08-06 |
2018-04-06 |
메디베이션 테크놀로지즈 엘엘씨 |
폴리(adp-리보오스)폴리머라아제 (parp)의 디히드로피리도프탈라지논 억제제
|
JP2010077286A
(ja)
|
2008-09-26 |
2010-04-08 |
Aica Kogyo Co Ltd |
シリコーン樹脂組成物および粘着フィルム
|
EP2350045A1
(en)
|
2008-10-21 |
2011-08-03 |
Vertex Pharmaceuticals Incorporated |
C-met protein kinase inhibitors
|
RU2011123647A
(ru)
|
2008-11-10 |
2012-12-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Соединения, полезные в качестве ингибиторов atr киназы
|
EP2379561B1
(en)
|
2008-11-25 |
2015-11-04 |
University Of Rochester |
Mlk inhibitors and methods of use
|
CA2744507A1
(en)
|
2008-12-05 |
2010-06-10 |
F.Hoffmann-La Roche Ag |
Pyrrolopyrazinyl urea kinase inhibitors
|
SG172248A1
(en)
|
2008-12-19 |
2011-07-28 |
Vertex Pharma |
Pyrazine derivatives useful as inhibitors of atr kinase
|
UY32351A
(es)
*
|
2008-12-22 |
2010-07-30 |
Astrazeneca Ab |
Compuestos de pirimidinil indol para uso como inhibidores de atr
|
CA2748099C
(en)
|
2008-12-22 |
2017-02-28 |
Array Biopharma Inc. |
7-phenoxychroman carboxylic acid derivatives
|
MX2011006332A
(es)
|
2008-12-23 |
2011-06-27 |
Abbott Lab |
Compuestos antivirales.
|
TW201036946A
(en)
|
2009-01-30 |
2010-10-16 |
Toyama Chemical Co Ltd |
N-acylanthranilic acid derivative or salt thereof
|
JP5353279B2
(ja)
|
2009-02-06 |
2013-11-27 |
Jnc株式会社 |
セレンテラミド又はその類縁体の製造方法
|
BRPI1008020A2
(pt)
|
2009-02-11 |
2016-03-15 |
Sunovion Pharmaceuticals Inc |
antagonistas e agonistas inversos h3 da histamina e métodos de uso dos mesmos
|
CN101537007A
(zh)
|
2009-03-18 |
2009-09-23 |
中国医学科学院血液病医院(血液学研究所) |
N-(噻吩-2)吡唑并[1,5-a]嘧啶-3-甲酰胺类化合物在制备抗恶性肿瘤药物方面的应用
|
JP2012522013A
(ja)
|
2009-03-27 |
2012-09-20 |
ザ ユーエービー リサーチ ファウンデーション |
調節ires媒介翻訳
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
AU2010272769B2
(en)
|
2009-07-13 |
2013-09-19 |
T&W Engineering A/S |
A hearing aid adapted for detecting brain waves and a method for adapting such a hearing aid
|
EP2454262B1
(en)
|
2009-07-15 |
2014-05-14 |
Abbott Laboratories |
Pyrrolopyrazine inhibitors of kinases
|
BR112012002677A2
(pt)
|
2009-08-07 |
2021-03-09 |
Dow Agrosciences Llc |
Moléculas de heteroaril-n-aril carbamatos, e composição pesticida
|
JP2011042639A
(ja)
|
2009-08-24 |
2011-03-03 |
Kowa Co |
ビフェニルピラジン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤
|
CN101671336B
(zh)
|
2009-09-23 |
2013-11-13 |
辽宁利锋科技开发有限公司 |
芳杂环并嘧啶衍生物和类似物及其制备方法和用途
|
DE102009043260A1
(de)
|
2009-09-28 |
2011-04-28 |
Merck Patent Gmbh |
Pyridinyl-imidazolonderivate
|
RU2017109664A
(ru)
|
2009-10-06 |
2019-01-23 |
Милленниум Фармасьютикалз, Инк. |
Гетероциклические соединения, используемые в качестве ингибиторов pdk1
|
CA2787121C
(en)
|
2010-01-18 |
2018-07-17 |
Mmv Medicines For Malaria Venture |
Aminopyridine derivatives as anti-malarial agents
|
US8518945B2
(en)
|
2010-03-22 |
2013-08-27 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
JP2013523805A
(ja)
*
|
2010-04-08 |
2013-06-17 |
ゾエティス・エルエルシー |
殺虫剤および殺ダニ剤としての置換3,5−ジフェニル−イソオキサゾリン誘導体
|
EP2558866B1
(en)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
EP2566858A2
(en)
|
2010-05-04 |
2013-03-13 |
Pfizer Inc. |
Heterocyclic derivatives as alk inhibitors
|
US9062008B2
(en)
|
2010-05-12 |
2015-06-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2011143399A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2569287B1
(en)
|
2010-05-12 |
2014-07-09 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
EP2569284B1
(en)
|
2010-05-12 |
2015-07-08 |
Vertex Pharmaceuticals Incorporated |
2-aminopyridine derivatives useful as inhibitors of atr kinase
|
WO2011143419A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazines useful as inhibitors of atr kinase
|
CA2798763A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
KR20130083387A
(ko)
|
2010-05-20 |
2013-07-22 |
에프. 호프만-라 로슈 아게 |
Syk 및 jak 억제제로서 피롤로피라진 유도체
|
CN103003281A
(zh)
|
2010-05-20 |
2013-03-27 |
弗·哈夫曼-拉罗切有限公司 |
作为JAK和SYK抑制剂的吡咯并[2,3-b]吡嗪-7-甲酰胺衍生物和它们的用途
|
NZ605627A
(en)
|
2010-06-23 |
2015-06-26 |
Vertex Pharma |
Pyrrolo-pyrazine derivatives useful as inhibitors of atr kinase
|
CN102311396B
(zh)
|
2010-07-05 |
2015-01-07 |
暨南大学 |
一种吡嗪类衍生物和其制备方法及在制药中的应用
|
EP2407478A1
(en)
|
2010-07-14 |
2012-01-18 |
GENETADI Biotech, S.L. |
New cyclotetrapeptides with pro-angiogenic properties
|
JP5782238B2
(ja)
|
2010-07-30 |
2015-09-24 |
ルネサスエレクトロニクス株式会社 |
電圧検出回路及びその制御方法
|
WO2012121939A2
(en)
|
2011-03-04 |
2012-09-13 |
Locus Pharmaceuticals, Inc. |
Aminopyrazine compounds
|
RU2013144579A
(ru)
|
2011-03-04 |
2015-04-10 |
Лексикон Фармасьютикалз, Инк. |
Ингибиторы киназы mst1 и способы их применения
|
WO2012127347A1
(en)
*
|
2011-03-22 |
2012-09-27 |
Pfizer Inc. |
Isoxazoline derivatives as antiparasitic agents
|
WO2012138938A1
(en)
|
2011-04-05 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazine compounds useful as inhibitors of tra kinase
|
EP2710006A1
(en)
|
2011-05-17 |
2014-03-26 |
Principia Biopharma Inc. |
Azaindole derivatives as tyrosine kinase inhibitors
|
WO2012178123A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2012178125A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2723747A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
US8846686B2
(en)
*
|
2011-09-30 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
US8853217B2
(en)
|
2011-09-30 |
2014-10-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
EP3878851A1
(en)
|
2011-09-30 |
2021-09-15 |
Vertex Pharmaceuticals Incorporated |
Process for making compounds useful as inhibitors of atr kinase
|
CN103957917A
(zh)
|
2011-09-30 |
2014-07-30 |
沃泰克斯药物股份有限公司 |
用atr抑制剂治疗胰腺癌和非小细胞肺癌
|
US8765751B2
(en)
|
2011-09-30 |
2014-07-01 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
EP2776419B1
(en)
|
2011-11-09 |
2016-05-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
EP2776420A1
(en)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
WO2013071094A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
US8841337B2
(en)
|
2011-11-09 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
US8846917B2
(en)
|
2011-11-09 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
PL2833973T3
(pl)
|
2012-04-05 |
2018-02-28 |
Vertex Pharmaceuticals Incorporated |
Związki użyteczne jako inhibitory kinazy ATR i ich terapie skojarzone
|
CN103373996A
(zh)
|
2012-04-20 |
2013-10-30 |
山东亨利医药科技有限责任公司 |
作为crth2受体拮抗剂的二并环衍生物
|
EP2904406B1
(en)
|
2012-10-04 |
2018-03-21 |
Vertex Pharmaceuticals Incorporated |
Method for measuring atr inhibition mediated increases in dna damage
|
WO2014062604A1
(en)
|
2012-10-16 |
2014-04-24 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
BR112015012454B1
(pt)
|
2012-12-07 |
2022-07-05 |
Vertex Pharmaceuticals Incorporated |
Compostos inibidores de atr quinase, seu uso e composição farmacêutica compreendendo os mesmos
|
JP6096005B2
(ja)
|
2013-02-26 |
2017-03-15 |
リンテック株式会社 |
シート剥離装置および剥離方法
|
SG11201604519PA
(en)
|
2013-12-06 |
2016-07-28 |
Vertex Pharma |
2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
|
EP3152212B9
(en)
|
2014-06-05 |
2020-05-27 |
Vertex Pharmaceuticals Inc. |
Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof
|
WO2015195740A1
(en)
|
2014-06-17 |
2015-12-23 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of chk1 and atr inhibitors
|